Optical Radiology Labs at Washington University in St. Louis School of Medicine

Welcome to the Optical Radiology Lab!

The Optical Radiology Lab harnesses the power of light to develop methods for understanding, diagnosing and treating human diseases. Our interdisciplinary and collaborative team of biologist, chemists, engineers, medical scientists and physicists are focused on uncovering new frontiers in medical research.  The unique strength of the ORL is the ability to develop complete solutions from conception, implementation, and validation to human clinical care.  We aim to change the way medicine is practiced.

Our site is currently under construction. Thank you for your patience. 

ORL Highlights




Congratulations Dr. Achilefu!

Samuel Achilefu, PhD, a scientist at Washington University School of Medicine in St. Louis, is the first recipient of the Breast Cancer Research Program Distinguished Investigator Award, from the U.S. Department of Defense. As part of the award, Achilefu will receive $4.5 million to support his work to use light to activate drugs and the immune system in the body



Awards and Recognitions: 

LeMoyne Habimana-Griffin, an MD/PhD graduate student mentored by Samuel Achilefu, PhD received a training grant from the NCI Alliance for Nanotechnology to further his education in nanomedicine.





Click here for the ARCHIVE  of ORL Highlights

Michel MTer-Pogossian Professorship Installation of Dr. S. Achilefu

Congratulations Dr. Achilefu!


















Center for Multiple Myeloma Nanotherapy, WUSTL




The Washington University Center for Multiple Myeloma Nanotherapy (CMMN) is a federally-funded program that was developed to improve the treatment outcomes of people with multiple myeloma. School of Medicine researchers have been awarded $13.7 million from the National Cancer Institute to create new therapies for multiple myeloma, a cancer of the immune system. Samuel Achilefu, PhD, and Gregory Lanza, MD, PhD, will lead the newly created Center for Multiple Myeloma Nanotherapy, where scientists will work to develop nanomaterials and drugs to treat the disease.

Multiple myeloma is a blood cancer affecting the plasma cells of the bone marrow. The bone marrow is the spongy center of the bone, which is the source of blood cells that carry hemoglobin and cells of the immune system. Although most patients with multiple myeloma respond to treatment initially, virtually all relapse and die from the disease.

The local center focuses on nanotherapy. “Nano” refers to the use of devices on a very small or molecular scale. The CMMN investigators aim to develop nano-sized materials and drug-delivering methods to battle multiple myeloma.

The CMMN is also a Center of Cancer Nanotechnology Excellence (CCNE), a distinction given by the National Cancer Institute (NCI), which is part of the National Institutes of Health. The CCNE is an alliance of select medical centers across the nation charged with developing nanotechnology-based methods to diagnose and treat cancer. Current methods to treat cancer include surgery, chemotherapy and radiation therapy.

Read more online in the Record and the MIR website.




The brain imaging system developed by the ORL has been in the news lately. "It has been 20 years since near-infrared spectroscopy was first used to investigate human brain function. The technique has subsequently been extended to offer high-resolution imaging of the cortex and has now become a viable alternative to functional magnetic resonance imaging." Cooper, Nature Photonics News and Views.


ORL Updates:
Alumni News- Samantha Corber

Michel M. Ter-Pogossian Professorship Installation

Novel nanoparticle made of common mineral may help keep tumor growth at bay

©2011 Mallinckrodt Institute of Radiology     Last Modified on August 1st